These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 20117266)
1. Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute Toxoplasmosis: an interplay of IFN-gamma and cytolytic T cells. Jongert E; Lemiere A; Van Ginderachter J; De Craeye S; Huygen K; D'Souza S Vaccine; 2010 Mar; 28(13):2556-64. PubMed ID: 20117266 [TBL] [Abstract][Full Text] [Related]
2. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Jongert E; de Craeye S; Dewit J; Huygen K Parasite Immunol; 2007 Sep; 29(9):445-53. PubMed ID: 17727568 [TBL] [Abstract][Full Text] [Related]
3. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963 [TBL] [Abstract][Full Text] [Related]
4. Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells. Lütjen S; Soltek S; Virna S; Deckert M; Schlüter D Infect Immun; 2006 Oct; 74(10):5790-801. PubMed ID: 16988257 [TBL] [Abstract][Full Text] [Related]
5. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis. Iborra S; Soto M; Carrión J; Alonso C; Requena JM Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690 [TBL] [Abstract][Full Text] [Related]
7. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice. Khan IA; Kasper LH J Immunol; 1996 Sep; 157(5):2103-8. PubMed ID: 8757333 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii. Xue M; He S; Cui Y; Yao Y; Wang H Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245 [TBL] [Abstract][Full Text] [Related]
9. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii. Khan IA; Casciotti L J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393 [TBL] [Abstract][Full Text] [Related]
10. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. Gazzinelli RT; Hakim FT; Hieny S; Shearer GM; Sher A J Immunol; 1991 Jan; 146(1):286-92. PubMed ID: 1670604 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis. Hoseinian Khosroshahi K; Ghaffarifar F; D'Souza S; Sharifi Z; Dalimi A Vaccine; 2011 Jan; 29(4):778-83. PubMed ID: 21095254 [TBL] [Abstract][Full Text] [Related]
12. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979 [TBL] [Abstract][Full Text] [Related]
13. Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells. Resende DM; Caetano BC; Dutra MS; Penido ML; Abrantes CF; Verly RM; Resende JM; Piló-Veloso D; Rezende SA; Bruna-Romero O; Fernandes AP; Gazzinelli RT Vaccine; 2008 Aug; 26(35):4585-93. PubMed ID: 18588933 [TBL] [Abstract][Full Text] [Related]
14. Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells. Yang TH; Aosai F; Norose K; Ueda M; Yano A J Immunol; 1995 Jan; 154(1):290-8. PubMed ID: 7995948 [TBL] [Abstract][Full Text] [Related]
15. A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection. Scorza T; D'Souza S; Laloup M; Dewit J; De Braekeleer J; Verschueren H; Vercammen M; Huygen K; Jongert E Infect Immun; 2003 Jan; 71(1):309-16. PubMed ID: 12496180 [TBL] [Abstract][Full Text] [Related]
16. Different profile of CD8+ effector T cells induced in Der p 1-allergic and naïve mice by DNA vaccination. Draghi M; Jarman ER; Grifantini R; Galli-Stampino L; Lamb JR; Valiante NM; Grandi G Eur J Immunol; 2002 Dec; 32(12):3720-8. PubMed ID: 12516566 [TBL] [Abstract][Full Text] [Related]
17. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Vercammen M; Scorza T; Huygen K; De Braekeleer J; Diet R; Jacobs D; Saman E; Verschueren H Infect Immun; 2000 Jan; 68(1):38-45. PubMed ID: 10603366 [TBL] [Abstract][Full Text] [Related]
18. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Yuan ZG; Zhang XX; Lin RQ; Petersen E; He S; Yu M; He XH; Zhou DH; He Y; Li HX; Liao M; Zhu XQ Vaccine; 2011 Sep; 29(38):6614-9. PubMed ID: 21762755 [TBL] [Abstract][Full Text] [Related]
19. Innate immunity in DNA vaccine with Toxoplasma gondii-heat shock protein 70 gene that induces DC activation and Th1 polarization. Makino M; Uemura N; Moroda M; Kikumura A; Piao LX; Mohamed RM; Aosai F Vaccine; 2011 Feb; 29(10):1899-905. PubMed ID: 21236236 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Mévélec MN; Bout D; Desolme B; Marchand H; Magné R; Bruneel O; Buzoni-Gatel D Vaccine; 2005 Aug; 23(36):4489-99. PubMed ID: 15935521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]